Biotech argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline July 26, 2026
Biotech Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm July 23, 2026
Biotech argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update July 22, 2026
Biotech Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom July 22, 2026
Biotech Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock July 21, 2026
Biotech Vivoryon Therapeutics N.V. to Report H1 2026 Financial Results and Business Updates on August 6, 2026; Annual General Meeting Planned for End of September 2026 July 21, 2026
Search
Biotech
July 26, 2026
July 23, 2026
July 23, 2026
July 23, 2026
July 22, 2026
July 22, 2026
July 22, 2026
July 22, 2026
July 21, 2026
July 21, 2026
